Increased levels of adipokine FABP4 are associated with several metabolic conditions and significantly higher levels are found in patients with HCC and metabolic syndrome compared to healthy individuals or those with HCV-related malignancy. This evidence concerns the gene FABP4 and hepatocellular carcinoma.